1 |
Maione S, Rossi F, Biggs CS, Fowler LJ, Whitton PS. AMPA receptors modulate extracellular 5-hydroxytryptamine concentration and metabolism in rat striatum in vivo. Neurochem Int 1997;30:299-304.
DOI
ScienceOn
|
2 |
Jan de Beur SM, Ding CL, LaBuda MC, Usdin TB, Levine MA. Pseudohypoparathyroidism 1b: exclusion of parathyroid hormone and its receptors as candidate disease genes. J Clin Endocrinol Metab 2000;85:2239-2246.
DOI
ScienceOn
|
3 |
Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet 2002; 114:347-353.
DOI
ScienceOn
|
4 |
Pauls DL, Alsobrook JP 2nd, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry 1995;152:76-84.
DOI
|
5 |
Inouye E. Similar and Dissimilar Manifestations of Obsessive-Compulsive Neuroses in Monozygotic Twins. Am J Psychiatry 1965;121: 1171-1175.
DOI
|
6 |
Rauch S, Whalen P, Dougherty D, Jenike M. Neurobiologic models of obsessive-compulsive disorder. In: Jenike M, Baer L, Minichiello W, editors. Obsessive-compulsive disorders: practical management. St Louis: Mosby;1998. p.222-253.
|
7 |
Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992;49:624-629.
DOI
ScienceOn
|
8 |
Rosario-Campos MC, Leckman JF, Mercadante MT, Shavitt RG, Prado HS, Sada P, et al. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry 2001;158:1899-1903.
DOI
|
9 |
Hemmings SM, Kinnear CJ, Lochner C, Niehaus DJ, Knowles JA, Moolman-Smook JC, et al. Early- versus late-onset obsessive-compulsive disorder: investigating genetic and clinical correlates. Psychiatry Res 2004;128:175-182.
DOI
ScienceOn
|
10 |
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989;46: 1006-1011.
DOI
ScienceOn
|
11 |
Zohar J, Chopra M, Sasson Y, Amiaz R, Amital D. Obsessive compulsive disorder: serotonin and beyond. World J Biol Psychiatry 2000; 1:92-100.
DOI
ScienceOn
|
12 |
Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry 1995;52: 53-60.
DOI
ScienceOn
|
13 |
Arnold PD, Macmaster FP, Richter MA, Hanna GL, Sicard T, Burroughs E, et al. Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder. Psychiatry Res 2009;172:136-139.
DOI
ScienceOn
|
14 |
Laurie DJ, Bartke I, Schoepfer R, Naujoks K, Seeburg PH. Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res Mol Brain Res 1997;51:23-32.
DOI
|
15 |
Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology 2004;174:530-538.
|
16 |
Fontenelle LF, Mendlowicz MV, Marques C, Versiani M. Early- and late-onset obsessive-compulsive disorder in adult patients: an exploratory clinical and therapeutic study. J Psychiatr Res 2003;37: 127-133.
DOI
ScienceOn
|
17 |
Loftis JM, Janowsky A. The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther 2003;97:55-85.
DOI
ScienceOn
|
18 |
Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988;45:1094-1099.
DOI
ScienceOn
|
19 |
Zohar J, Gross-Isseroff R, Hermesh H, Weizman A. Is there sexual dimorphism in obsessive-compulsive disorder? Neurosci Biobehav Rev 1999;23:845-849.
DOI
ScienceOn
|
20 |
Lee H, Namkoong K, Lee M, Min S, Kim S, Song D, et al. Epidemiologic study of psychiatry in Kang-Hwa Do (III) - Life time prevalence of major psychiatric disorders. J Korean Neuropsychiatr Assoc 1989;28:984-999.
|
21 |
Lee J. Epidemiologic study of psychiatric disorder in Korea (XII)- Prevalence of obsessive compulsive disorder. J Korean Neuropsychiatr Assoc 1994;33:5-17.
|
22 |
Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
DOI
ScienceOn
|
23 |
Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive- compulsive disorder. Arch Gen Psychiatry 2006;63:778-785.
DOI
ScienceOn
|
24 |
Cavallini MC, Pasquale L, Bellodi L, Smeraldi E. Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet 1999;88:38-43.
DOI
ScienceOn
|
25 |
Albert U, Picco C, Maina G, Forner F, Aguglia E, Bogetto F. [Phenomenology of patients with early and adult onset obsessive-compulsive disorder]. Epidemiol Psichiatr Soc 2002;11:116-126.
DOI
|
26 |
Busatto GF, Buchpiguel CA, Zamignani DR, Garrido GE, Glabus MF, Rosario-Campos MC, et al. Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: an exploratory SPECT study. J Am Acad Child Adolesc Psychiatry 2001;40: 347-354.
DOI
ScienceOn
|
27 |
Bogetto F, Venturello S, Albert U, Maina G, Ravizza L. Gender-related clinical differences in obsessive-compulsive disorder. Eur Psychiatry 1999;14:434-441.
DOI
ScienceOn
|
28 |
Kim C, KA. C, Koo M, Nam Y, Hong C, Lee H. Clinical characteristics and courses in patients with early-onset and late-onset obsessive- compulsive disorder. Korean J Psychopharmacol 2003;14:163-171.
|
29 |
Kwon J, Lee D, Yoon D. Clinical characteristics of obsessive-compulsive disorder (Inpatient record study). J Korean Neuropsychiatr Assoc 1998;37:225-233.
|
30 |
Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997;154:911-917.
DOI
|
31 |
Zohar AH, Pauls DL, Ratzoni G, Apter A, Dycian A, Binder M, et al. Obsessive-compulsive disorder with and without tics in an epidemiological sample of adolescents. Am J Psychiatry 1997;154:274-276.
DOI
|
32 |
Swedo SE, Rapoport JL, Leonard H, Lenane M, Cheslow D. Obsessive- compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry 1989; 46:335-341.
DOI
ScienceOn
|
33 |
Delorme R, Golmard J, Chabane N, Millet B, Krebs M, Mouren-Simeoni MC, et al. Admixture analysis of age at onset in obsessive-compulsive disorder. Psychol Med 2005;35:237-243.
DOI
ScienceOn
|
34 |
Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000;39:1096-1103.
DOI
ScienceOn
|
35 |
McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive- compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 1994;51:302-308.
DOI
ScienceOn
|
36 |
Pian KL, Westenberg HG, van Megen HJ, den Boer JA. Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder. Psychopharmacology 1998;140:365-370.
DOI
|
37 |
Khanna S, John JP, Reddy LP. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder. Psychoneuroendocrinology 2001;26:209-223.
DOI
ScienceOn
|